Kestra Advisory Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $383K | Sell |
5,970
-890
| -13% | -$57.1K | ﹤0.01% | 2160 |
|
|
2025
Q1 | $435K | Sell |
6,860
-229
| -3% | -$14.5K | ﹤0.01% | 1907 |
|
|
2024
Q4 | $472K | Buy |
7,089
+2,383
| +51% | +$159K | ﹤0.01% | 1904 |
|
|
2024
Q3 | $329K | Sell |
4,706
-220
| -4% | -$15.4K | ﹤0.01% | 2026 |
|
|
2024
Q2 | $319K | Sell |
4,926
-680
| -12% | -$44.1K | ﹤0.01% | 2070 |
|
|
2024
Q1 | $363K | Buy |
5,606
+40
| +0.7% | +$2.59K | ﹤0.01% | 1871 |
|
|
2023
Q4 | $366K | Sell |
5,566
-796
| -13% | -$52.4K | ﹤0.01% | 1720 |
|
|
2023
Q3 | $363K | Buy |
6,362
+254
| +4% | +$14.5K | ﹤0.01% | 1550 |
|
|
2023
Q2 | $374K | Sell |
6,108
-786
| -11% | -$48.2K | ﹤0.01% | 1476 |
|
|
2023
Q1 | $433K | Sell |
6,894
-12
| -0.2% | -$753 | ﹤0.01% | 1352 |
|
|
2022
Q4 | $439K | Sell |
6,906
-98
| -1% | -$6.22K | ﹤0.01% | 1490 |
|
|
2022
Q3 | $413K | Buy |
7,004
+89
| +1% | +$5.25K | ﹤0.01% | 1419 |
|
|
2022
Q2 | $399K | Buy |
6,915
+1,498
| +28% | +$86.4K | ﹤0.01% | 1457 |
|
|
2022
Q1 | $336K | Buy |
+5,417
| New | +$336K | ﹤0.01% | 1526 |
|
|
2021
Q1 | – | Sell |
-2,906
| Closed | -$206K | – | 1999 |
|
|
2020
Q4 | $206K | Buy |
+2,906
| New | +$206K | ﹤0.01% | 1705 |
|